Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

The Role of NMR and Mass Spectroscopy in Glycan Analysis

January 02, 2014

NMR analysis provides crucial structural information of synthesized glycans while LC-MS/MS is ideal for quantitation of free sugars in biological matrices.

Challenges and Strategies for the Downstream Purification and Formulation of Fab Antibody Fragments

January 02, 2014

Antibody fragments pose unique challenges in terms of recovery, purification, and formulation.

Q&A with Roger Hayes, MPI Research

January 02, 2014

Roger Hayes of MPI Research discusses highly potent drug development.

Early Communication with Regulators is Essential for SMEs

January 02, 2014

With SMEs gaining wider recognition as the powerhouse of research and innovation in Europe, regulatory agencies are urging companies to engage with regulators early in the drug-development process.

ProBioGen, Emergent BioSolutions Partner in Vaccine Manufacturing

December 19, 2013

ProBioGen signs agreement with Emergent BioSolutions for access to ProBioGen's avian AGE1.CR cell line.

Pfenex Awarded Anthrax Vaccine Contract

December 19, 2013

Leidos Holdings awards Pfenex a subcontract in support of the development of an anthrax vaccine.

CMC Biologics and OncoSynergy Form Pact

December 19, 2013

CMC Biologics and OnoSynergy form an agreement from cell-line development.

Pfizer Appoints Head of Vaccines

December 19, 2013

Pfizer appoints management changes to take effect in 2014.

Preventing Off-weight Tablets

December 18, 2013

Equipment and Processing Report

Operator training, preventive maintenance, and regularly scheduled calibration help prevent the manufacture of off-weight tablets.

Biogen Idec, Samsung Bioepis Target Anti-TNF Biosimilars in Europe

December 18, 2013

Biogen and Samsung Bioepis, a joint venture between Samsung Biologics and Biogen Idec, advance plans for anti-TNF biosimilar product candidates.